Regn class action notice: glancy prongay & murray llp files securities fraud lawsuit on behalf of regeneron pharmaceuticals, inc. investors

Los angeles--(business wire)--glancy prongay & murray llp (“gpm”) announces that it has filed a class action lawsuit in the united states district court for the southern district of new york, captioned radtke v. regeneron pharmaceuticals, inc., et al., case no. 25-cv-145, on behalf of persons and entities that purchased or otherwise acquired regeneron pharmaceuticals, inc. (“regeneron” or the “company”) (nasdaq: regn) securities between november 2, 2023 and october 30, 2024, inclusive (the.
REGN Ratings Summary
REGN Quant Ranking